The full structure of a MEDICI strategy report - the same fields the product emits, in the same order, with a fingerprint you can verify yourself.
The brief
Operation title
Enterprise healthcare vs mid-market ICP
Market domain
Enterprise healthcare
Problem statement
I think there is an opportunity in larger healthcare groups, but I’m not sure the market is ready. They’re already ~40% of our pipeline, even though our product wasn’t built for them. I’m deciding whether to spend the next 6 months building for enterprise or keep optimizing for our mid-market ICP. Can you research what’s changed and give me enough evidence to make the call?
Balanced mode
01
Executive Summary
Context synthesis and strategic positioning
Prioritize growth in mid-size regional health systems for the next 6 months while building foundational enterprise-grade procurement and compliance AI modules. Mid-size systems offer faster sales cycles (~12 months) and easier deployment, representing a high-opportunity, underpenetrated market segment (c19,c22). The biggest risk is accelerating demand from large enterprises for turnkey solutions with multi-site real-world evidence, which would require a swift pivot if pipeline conversion rates and paid pilot volume surge significantly.
02
Market Opportunities
Ranked by priority, each with a market-size estimate
high priority
Enterprise-Grade Clinical and Economic Evidence Packages
Large health systems require rigorously validated multi-site clinical outcomes and economic data to adopt AI at scale, making this a valuable but slow-to-monetize segment demanding significant investment in evidence generation.
Multi-billion USD
enterpriseclinical-evidenceeconomic-modeling
high prioritylow-hanging fruit
Mid-Size Regional Health Systems as Enterprise-Lite
Mid-size systems with 200-800 beds are underpenetrated, have shorter sales cycles, and seek operational cost reductions through affordable AI solutions, presenting the fastest scalable runway for near-term growth.
Few hundred million USD to low billion USD
mid-marketregional-health-systemsfast-sales-cycle
medium priority
AI-Driven Procurement and Compliance Automation
The complexity and fragmentation of healthcare procurement create a rapid growth opportunity for AI compliance and procurement tools, especially for large enterprise clients requiring audit and regulatory readiness.
Hundreds of millions USD
procurementcomplianceenterprise
03
Growth Strategy
Go-to-market, target segments, key metrics and timeline
Lead with targeting mid-size regional health systems using evidence-based paid pilots, followed by strategic GPO partnerships and EHR integration pilots to build enterprise readiness.
Target segments
Mid-size regional health systems (200-800 beds)
Key metrics
Pilot-to-paid conversion rate >30% within 6 months
Retention rate >70% at 12 months
Month 1-3: secure pilots, define MVP modules, initial hires; Month 4-6: deploy pilots, collect interim evidence, expand sales pipeline; Month 7+: evaluate enterprise pivot based on pilot outcomes and pipeline conversion
04
Pricing Model
Tiers with features, and the rationale behind the structure
enterprise
Mid-market Tier
$100K-$250K annually
Single-site deployment
Basic integration
Standard support
ROI-based milestone discounts
Enterprise Tier
40-60% premium over mid-market pricing
Multi-site deployment
Full Epic and Oracle integration
Compliance and procurement AI modules
Dedicated account team
Flexible contract terms
An adaptive enterprise pricing model balances payer reimbursement uncertainty with ROI milestones, enabling pilot-to-paid transitions while capturing higher value from large health systems.
05
Partnership Strategy
Who to partner with, and what the partnership is for
Engage Group Purchasing Organizations (GPOs) like Vizient, Premier, and HealthTrust to accelerate procurement buy-in and pilot scale; collaborate with major EHR vendors Epic and Oracle for seamless integration; pilot with AI compliance startups Readily and Brellium to embed procurement and regulatory automation capabilities.
06
Compliance Notes
Regulatory and data-handling constraints on the plan
HIPAA, HITRUST, and FDA digital health regulations require embedding compliance checkpoints in product sprints and hiring a dedicated Regulatory & Compliance Officer to lead audit readiness and government alignment.
07
Engineering Directives
Technical recommendations for the build team
Develop procurement and compliance AI modules with audit and governance features by month 6
Build interoperability layers for Epic and Oracle EHR platforms with test integrations
Embed compliance tracking and reporting into product from day 30 onwards
Implement adaptive pricing and contract management features supporting milestone-based billing
Optimize data capture and analytics pipelines to generate clinical and economic evidence from pilot sites
08
30 / 60 / 90 Day Plan
Sequenced action items by time horizon
First 30 days
Form cross-functional growth task force with clinical, product, sales, regulatory leaders
Secure 2-3 mid-size regional system pilots with commitment to interim evidence capture
Define MVP procurement/compliance module requirements with stakeholder inputs
Initiate contacts with Epic and Oracle integration consultants
By day 60
Deploy MVP to pilot sites and implement structured data collection protocols
Hire Clinical Evidence Manager and Enterprise Account Executive
This hash is computed from the report’s content. Verify it yourself: take the JSON below and hash the file you receive.
shasum -a 256 medici-sample-report.json
Hash the file as delivered rather than a copy you have re-saved. The fingerprint covers the exact bytes, so reformatting the JSON - even just adding indentation - produces a different hash. That is the property that makes it tamper-evident.
What this does not do: it does not prove the analysis is correct, it is not a timestamp, and it is not a legal attestation. It proves integrity, not truth.